On May 13, 2025, Davis Polk partners David Bauer and Yasin Keshvargar will be among the speakers at L Suite’s Biotech Workshop, which will focus on emerging compliance challenges, evolving…
Davis Polk partner Yasin Keshvargar discussed the impact of tariffs on corporate disclosure trends with Law360.The article notes that approximately 584 U.S.-listed companies have mentioned…
Davis Polk partner Yasin Keshvargar discussed the recent uptick in capital markets deal activity in the biotech space and the outlook for the IPO market with the Financial Times.“There’s a…
Davis Polk partner Yasin Keshvargar was recently quoted in Law360 discussing the busy June IPO market. The article notes that Davis Polk worked on 23 IPOs in June, more than any other…
Law360 has named five Davis Polk partners among its 2021 Rising Stars:
Yasin Keshvargar – Capital Markets (read the full profile)
Angela Libby – Energy (read the full profile)
Emily…
Davis Polk partner Yasin Keshvargar was quoted in a Business Insider article discussing the life sciences IPO boom in 2020. Keshvargar noted that 2020 brought more capital markets…
Davis Polk partner Yasin Keshvargar was quoted in a Business Insider article discussing IPO trends of 2020 and the outlook for IPOs in 2021. Keshvargar explained that many biotech companies…
The National Law Journal has named Davis Polk partner Yasin Keshvargar among its 2020 “Crisis Leadership Trailblazers.” Honorees represent individuals who have launched new initiatives to…
On July 29, 2020, Davis Polk partner Yasin Keshvargar will speak at the New York Stock Exchange’s upcoming Expert Call Series: International Biotech - Accessing the U.S. Capital…
New York, NY, June 26, 2019 – Davis Polk has announced that Yang Chu, Hilary Dengel, Vanessa Jackson, Yasin Keshvargar, Angela Libby, Fiona Moran, Emily Roberts, Evan Rosen, Darren…
